189 research outputs found

    Data report on three datasets: Mortality patterns between agricultural and non-agricultural ward areas

    Get PDF
    The health of the farming community in Northern Ireland (NI) requires further research as previous mortality studies have reported contradictory results regarding farmers’ health outcomes compared against other occupations and the general population. This study collated the NINIS area-level farm census with the population census information across 582 non-overlapping wards of NI to compile three mortality datasets (2001, 2011, and pooled dataset) (NISRA 2019). These datasets allow future researchers to investigate the influence of demographic, farming, and economic predictors on all-cause mortality at the ward level. The 2001 and 2011 mortality datasets were compiled for cross-sectional analyses and subsequently pooled for longitudinal analyses. Findings from these datasets will provide evidence of the influence of Farming Intensity scores influence on death risk within the wards for future researchers to utilise. This data report will aid in the understanding of socio-ecological variables’ additive contribution to the risk of death at the ward level within NI. This data report is of interest to the One Health research community as it standardises the environment−human−animal data to pave the way towards a new One Health research paradigm. For example, future researchers can use this nationally representative data to investigate whether agriculturally saturated wards have a higher mortality risk than non-agriculturally based wards of NI

    Maternal sociodemographic characteristics, early pregnancy behaviours, and livebirth outcomes as congenital heart defects risk factors - Northern Ireland 2010-2014

    Get PDF
    Abstract Background Congenital Heart Defects (CHD) is the most commonly occurring congenital anomaly in Europe and a major paediatric health care concern. Investigations are needed to enable identification of CHD risk factors as studies have given conflicting results. This study aim was to identify maternal sociodemographic characteristics, behaviours, and birth outcomes as risk factors for CHD. This was a population based, data linkage cohort study using anonymised data from Northern Ireland (NI) covering the period 2010-2014. The study cohort composed of 94,067 live births with an outcome of 1162 cases of CHD using the International Statistical Classification of Diseases and Related Health Problems (ICD)-10 codes and based on the European Surveillance of Congenital Anomalies (EUROCAT) grouping system for CHD. CHD cases were obtained from the HeartSuite database (HSD) at the Royal Belfast Hospital for Sick Children (RBHSC), maternal data were extracted from the Northern Ireland Maternity System (NIMATS), and medication data were extracted from the Enhanced Prescribing Database (EPD). STATA version 14 was used for the statistical analysis in this study, Odds Ratio (OR), 95% Confident intervals (CI), P value, and logistic regression were used in the analysis. Ethical approval was granted from the National Health Service (NHS) Research Ethics Committee. Result In this study, a number of potential risk factors were assessed for statistically significant association with CHD, however only certain risk factors demonstrated a statistically significant association with CHD which included: gestational age at first booking (AOR = 1.21; 95% CI = 1.04-1.41; P < 0.05), family history of CHD or congenital abnormalities and syndromes (AOR = 4.14; 95% CI = 2.47-6.96; P < 0.05), woman’s smoking in pregnancy (AOR = 1.22; 95% CI = 1.04-1.43; P < 0.05), preterm birth (AOR = 3.01; 95% CI = 2.44-3.01; P < 0.05), multiple births (AOR = 1.89; 95% CI = 1.58-2.60; P < 0.05), history of abortion (AOR = 1.12; 95% CI = 1.03-1.28; P < 0.05), small for gestational age (SGA) (AOR = 1.44; 95% CI = 1.22-1.78; P < 0.05), and low birth weight (LBW) (AOR = 3.10; 95% CI = 2.22-3.55; P < 0.05). Prescriptions and redemptions of antidiabetic (AOR = 2.68; 95% CI = 1.85-3.98; P < 0.05), antiepileptic (AOR = 1.77; 95% CI = 1.10-2.81; P < 0.05), and dihydrofolate reductase inhibitors (DHFRI) (AOR = 2.13; 95% CI = 1.17-5.85; P < 0.05) in early pregnancy also showed evidence of statistically significant association with CHD. Conclusion The results of this study suggested that there are certain maternal sociodemographic characteristics, behaviours and birth outcomes that are statistically significantly associated with higher risk of CHD. Appropriate prevention policy to target groups with higher risk for CHD may help to reduce CHD prevalence. These results are important for policy makers, obstetricians, cardiologists, paediatricians, midwives and the public

    An Evaluation of Personalised Supports to Individuals with Disabilities and Mental Health Difficulties

    Get PDF
    corecore